3
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Thrombotic Microangiopathy After Bone Marrow Transplantation

Pages 180-181 | Published online: 11 Jun 2009

References

  • Kierdorf H., Maurin M., Heinz B. Cyclosporine for thrombotic thrombocytopenic purpura. Ann Intern Med 1993; 118: 987
  • DaSilva K., Pasquale D., Tsan M. F., Chikkappa G., et al. Cyclosporine A (CyA), an effective therapy for thrombotic thrombocytopenic purpura (TTP). Blood 1993; 82(Suppl)411a
  • Gable P. S., Smith W. S., Millard F. E. Cyclosporine in relapsed thrombotic thrombocytopenia purpura. Blood 1993; 82(Suppl)604a
  • Atkinson K., Biggs J. C., Hayes J., et al. Cyclosporine A associated nephrotoxicity in the first 100 days after allogeneic bone marrow transplantation: Three distinct syndromes. Br J Haematol 1983; 54: 59–67
  • Loomis L. J., Aronson A. J., Rudinsky R., et al. Hemolytic ureraic syndrome following bone marrow transplantation: A case report and review of the literature. Am J Kidney Dis 1989; 14: 324–328
  • Holler E., Kolb H. J., Hiller E., et al. Microangiopathy in patients on Cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation. Blood 1989; 73: 2018–2024
  • Rabinowe S. N., Soiffer R. J., Tarbell N. J., et al. Hemolytic uremic syndrome following bone marrow transplantation in adults for hematologic malignancies. Blood 1991; 77: 1837–1844

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.